Project Details
Description
This study is an extension of the DISTOL-1 study that was a placebo controlled medication study for digital ulcers. It allows for those participants who have successfully completed the initial DISTOL-1 study an opportunity to use the drug for up to four
| Status | Finished |
|---|---|
| Effective start/end date | 3/1/10 → 8/1/14 |
Funding
- UNITED THERAPEUTICS CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.